Large Cap Biotech Analyst Fye holds a conference call with Chairman & CEO Lewis on May 10 at 12 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on INSM: Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update Insmed reports Q1 EPS ($1.06), consensus ($1.23) Is INSM a Buy, Before Earnings? Roblox upgraded, Qualcomm initiated: Wall Street’s top analyst calls Insmed initiated with a Buy at Truist